Can I Take Lion's Mane with Losartan?

What Is Losartan and Why Do Women Take It?

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for hypertension, heart failure, and diabetic nephropathy. For women, the reasons to be on it span more than just blood pressure numbers.

Women-specific uses

Perimenopausal and postmenopausal women see a sharp rise in hypertension risk. Before menopause, estrogen offers some vascular protection; after it, systolic blood pressure climbs at roughly twice the rate seen in men of the same age, according to data reviewed by the American Heart Association (Go et al., Circulation, 2014). Women with polycystic ovary syndrome (PCOS) also carry a disproportionate burden of hypertension and insulin resistance, and losartan is sometimes chosen for them because it has a neutral-to-favorable metabolic profile.

Women with diabetic nephropathy, a complication seen in both type 1 and type 2 diabetes, are candidates for losartan because RENAAL trial data showed a 16% reduction in the composite of doubling serum creatinine, end-stage renal disease, or death with losartan 50 to 100 mg daily versus placebo.

Losartan is also prescribed off-label for migraine prevention, and women account for roughly 75% of migraine diagnoses, so the overlap with the lion's mane-curious population is real.

How losartan works

Losartan blocks the AT1 receptor, preventing angiotensin II from causing vasoconstriction and aldosterone release. The result is vasodilation and a lower blood pressure, typically a systolic drop of 10 to 15 mmHg at steady state on 50 to 100 mg daily.

What Is Lion's Mane and Why Are Women Taking It?

Lion's mane (Hericium erinaceus) is a functional mushroom used primarily for cognitive support and nerve health. Its main bioactive compounds are hericenones (found in the fruiting body) and erinacines (found in the mycelium), both of which stimulate nerve growth factor (NGF) synthesis.

Women reach for lion's mane across several life stages:

• Perimenopause and menopause. Cognitive symptoms such as brain fog and memory lapses affect up to 60% of women during the menopausal transition. Lion's mane is marketed heavily for exactly these complaints.
• Postpartum. Sleep-deprived mothers use it for focus, though data in this group is essentially absent.
• Reproductive years. Women with ADHD or anxiety sometimes layer lion's mane on prescription regimens, raising interaction questions.

A 2020 double-blind RCT in adults with mild cognitive impairment found that Hericium erinaceus supplementation over 16 weeks improved cognitive function scores versus placebo, though the sample was small (n=31) and the population was mixed-sex with no sex-stratified subgroup analysis published. This is an important evidence gap: we do not know whether the NGF-stimulating response differs by hormonal status.

The Interaction Question: What Could Go Wrong?

There is no entry for a losartan plus lion's mane interaction in the FDA adverse-event database (FAERS) as a documented case, and no human pharmacokinetic study has specifically examined this pairing. What exists is a set of biologically plausible concerns built from each substance's individual pharmacology. Here is a plain breakdown.

Concern 1: Additive blood-pressure lowering

Lion's mane contains beta-glucans and other polysaccharides that have shown modest hypotensive effects in animal models. A study in spontaneously hypertensive rats found that oral Hericium erinaceus extract reduced systolic blood pressure by approximately 15 mmHg over four weeks compared to controls. That mechanism appears partly related to ACE-inhibitory activity in the polysaccharide fraction, which sits on a similar physiological pathway to what losartan inhibits, though by a different receptor-level mechanism.

The practical concern: if you are already at blood-pressure goal on losartan 50 mg, adding a supplement with its own mild antihypertensive activity could tip you into symptomatic hypotension, especially on standing (orthostatic hypotension). Women tend to have a smaller circulating blood volume than men of similar weight, which makes them somewhat more prone to positional dizziness from blood-pressure-lowering medications.

Concern 2: Antiplatelet and anticoagulant effects

Lion's mane has shown platelet aggregation inhibitory activity in vitro. A study examining the ethanol extract of Hericium erinaceus found inhibition of collagen-induced platelet aggregation at concentrations of 0.5 to 1 mg/mL. Losartan itself has a mild independent antiplatelet property at higher doses through its uricosuric effect and AT1 receptor blockade.

Alone, neither agent is a strong blood thinner. Together, the combined antiplatelet signal may be meaningful in women who are also on aspirin or NSAIDs, or who have inherently prolonged bleeding times. Heavy menstrual bleeding (HMB) is a real clinical concern here: women with HMB or fibroids taking any combination of antiplatelet agents should flag this to their gynecologist.

Concern 3: CYP2C9 and pharmacokinetic considerations

Losartan is primarily metabolized by CYP2C9 to its active metabolite EXP3174, which carries most of the blood-pressure-lowering effect. No published data shows that lion's mane extracts significantly induce or inhibit CYP2C9 in humans. The pharmacokinetic interaction risk is currently theoretical and appears low. This is an honest evidence gap.

Women who are CYP2C9 poor metabolizers (a genetic variant affecting roughly 5 to 8% of women of European ancestry) already convert less losartan to EXP3174, meaning their losartan effect is blunted. If lion's mane eventually proved to affect CYP2C9 activity, this subset could be affected differently. No trial has examined this.

Life-Stage Breakdown: Does the Risk Change Depending on Where You Are?

Reproductive years (ages 18 to 40)

Women of childbearing age on losartan must use effective contraception. See the pregnancy section below. Lion's mane has no established reproductive toxicology data in humans. If you are planning to conceive, both should be reviewed by your prescriber before you try.

Perimenopause (roughly ages 45 to 55)

This is the group most likely to be taking losartan for newly diagnosed hypertension and simultaneously reaching for lion's mane for cognitive symptoms. The additive blood-pressure concern is most relevant here. Perimenopausal hormone fluctuations already cause vascular instability and hot-flush-associated blood-pressure spikes, so your baseline BP may be more variable than it was five years ago. Monitoring at home with a validated cuff at the same time each morning gives you real data to share with your clinician.

Postmenopause (ages 55+)

Established hypertension on losartan plus interest in cognitive supplements converges in this group. The antiplatelet concern becomes more relevant if you are also on low-dose aspirin for cardiovascular prevention, which many postmenopausal women are. A 2022 USPSTF statement changed aspirin recommendations, but some women remain on it. Three antiplatelet agents (aspirin, losartan's mild effect, lion's mane) is a combination worth discussing.

PCOS

Women with PCOS on losartan for blood pressure or kidney protection and who take lion's mane for cognitive symptoms or inflammation should note that lion's mane's anti-inflammatory beta-glucans have not been studied in PCOS specifically. The interaction profile does not change, but the baseline inflammatory burden may mean blood pressure is more volatile.

Pregnancy, Lactation, and Contraception: Read This Carefully

Losartan is contraindicated in the second and third trimesters of pregnancy.

The FDA classifies losartan as Pregnancy Category D based on human data showing fetal harm. Exposure during the second and third trimesters can cause fetal renal dysplasia, oligohydramnios, neonatal renal failure, skull hypoplasia, and death. The ACOG Practice Bulletin on Chronic Hypertension in Pregnancy explicitly lists ARBs including losartan as drugs to discontinue before conception or immediately upon pregnancy confirmation.

If you are a woman of reproductive age taking losartan, you need a reliable form of contraception. If you become pregnant while taking losartan, contact your prescriber the same day. The drug will need to be switched to a pregnancy-safe antihypertensive such as labetalol, nifedipine, or methyldopa.

What about lion's mane in pregnancy?

No human safety data exists for lion's mane supplementation during pregnancy. Animal reproductive toxicology studies have not been published in peer-reviewed literature to a standard that allows reassurance. The conservative clinical position is to avoid lion's mane in pregnancy entirely until human data exists.

Lactation

Losartan transfer into breast milk has not been adequately studied in humans. Animal data shows transfer does occur. The LactMed database notes that because of the potential for serious adverse effects in the nursing infant, losartan is generally not recommended during breastfeeding. Alternative antihypertensives with better lactation data (such as nifedipine, enalapril, or labetalol) are preferred.

Lion's mane in lactation: no data. Avoid.

Who Should Be Especially Cautious?

Not every woman on losartan faces the same risk profile from adding lion's mane. Here is where caution is highest:

Think twice before combining if you:

• Already have blood pressure at or below 110/70 mmHg on current treatment
• Are also taking aspirin, clopidogrel, warfarin, or any NSAID regularly
• Have fibroids with heavy menstrual bleeding
• Are pregnant, trying to conceive, or breastfeeding
• Take other blood-pressure medications (amlodipine, hydrochlorothiazide) alongside losartan

The combination is lower risk if you:

• Have blood pressure running 130 to 140 systolic on losartan and are not yet at goal
• Are not on any antiplatelet or anticoagulant agents
• Plan to monitor blood pressure at home at least weekly after starting lion's mane
• Have discussed the plan with your prescriber and will follow up in 4 to 6 weeks

This is not a binary "safe versus dangerous" situation. The absence of a documented interaction in humans does not mean no interaction exists.

What the Evidence Is Actually Missing

Women are under-represented in supplement pharmacokinetic trials. The lion's mane cognitive RCTs published to date have not reported sex-stratified outcome data, so we cannot say whether the NGF-stimulating effect differs across the menstrual cycle or by menopausal status. Estrogen upregulates NGF receptors (TrkA), which suggests the response to lion's mane could theoretically differ by hormonal status, but this is mechanistic speculation, not trial data.

The antiplatelet data on lion's mane comes entirely from in vitro and animal models. No human platelet-function study has measured the effect of a standard commercial lion's mane dose (typically 500 to 3,000 mg daily of fruiting body extract) on bleeding time or platelet aggregation. That gap matters when counseling women with heavy periods or those on concurrent antithrombotic therapy.

Honestly: the available evidence does not let us draw a firm conclusion either way. What it does let us say is that the biological plausibility of an interaction exists, and monitoring is warranted.

Practical Steps If You Want to Take Both

If your prescriber agrees that adding lion's mane is reasonable, here is a sensible monitoring approach:

1. Baseline blood pressure log. Take readings at the same time each morning for two weeks before starting lion's mane. This gives your clinician a true baseline.
2. Start low. Begin with 500 mg daily of a standardized fruiting-body extract rather than jumping to 2,000 to 3,000 mg.
3. Recheck blood pressure at two and four weeks. A drop of more than 10 mmHg systolic from baseline warrants a call to your prescriber.
4. Watch for symptoms. Dizziness on standing, unusual bruising, or prolonged bleeding from minor cuts are signals to stop lion's mane and report them.
5. Medication reconciliation at every visit. Lion's mane is a supplement, not a prescription, but it belongs on your medication list given to every clinician you see.
6. Lab timing. If your prescriber orders a basic metabolic panel (which is standard follow-up on losartan for renal function and potassium), time it alongside your four-week blood-pressure review.

"The challenge with functional mushroom supplements is that patients view them as food, not pharmacology," says Dr. Maya Okafor, MD, WomanRx medical reviewer. "For a woman on losartan whose blood pressure is finally controlled, an unmonitored addition of any agent with blood-pressure-modifying properties deserves the same conversation we would give a new prescription."

Frequently Asked Questions